fasudil (Garvan Institute of Medical Research)

N/A

Report date: 2025/03/18 18:20:37
NME

Base Information

Drug Namefasudil (Garvan Institute of Medical Research)
Drug Alias Namefasudil
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated kinases inhibitors
TargetsRho-associated kinases
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGarvan Institute Of Medical Research
China Registration ClassN/A

Develop Information

Active CompaniesGarvan Institute Of Medical Research
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A